Law360, New York (February 21, 2012, 8:27 PM ET) -- Abbott Laboratories Inc., already facing a U.S. Department of Justice investigation over Depakote, disclosed Tuesday that the attorneys general of eight states are investigating whether the company's promotion of improper off-label uses for the anti-seizure drug Depakote violated state laws.
The attorneys general of Florida, Illinois, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina and Texas have formed a committee on behalf of themselves and other state attorneys general to investigate possible state law violations in Abbott's sales and marketing activities for Depakote, according to Abbott's annual...
8 States Probe Abbott's Marketing Of Anti-Seizure Drug
To view the full article, take a free trial now.
